Created at	Source	Raw Value	Validated value
July 20, 2023, 4 p.m.	usa	non-inferiority of the seroconversion rate and IgG antibody level against measles, rubella, and mumps;non-inferiority of the seroconversion rate and IgG antibody level against varicella;non-inferiority of the seroconversion rate and neutralising antibody level against SARS-CoV-2	non-inferiority of the seroconversion rate and IgG antibody level against measles, rubella, and mumps;non-inferiority of the seroconversion rate and IgG antibody level against varicella;non-inferiority of the seroconversion rate and neutralising antibody level against SARS-CoV-2